BmLAO-f3

General Information


DRACP ID  DRACP03474

Peptide Name   BmLAO-f3

Sequence  IYYPPNHNFP

Sequence Length  10

UniProt ID  B3EWI9 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03474

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C62H80N14O15

Absent amino acids  ACDEGKLMQRSTVW

Common amino acids  P

Mass  142210

Pl  7.53

Basic residues  1

Acidic residues  0

Hydrophobic residues  2

Net charge  1

Boman Index  -1032

Hydrophobicity  -103

Aliphatic Index  39

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  2980

Absorbance 280nm  331.11

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22438972

Title  Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  4695

DRACP is developed by Dr.Zheng's team.